Glenda Halliday | |
---|---|
Occupation | Neuroscientist |
Awards | NSW Scientist of the Year (2022) |
Academic background | |
Alma mater | University of New South Wales |
Thesis | The organization of the ventromedial mesencephalic tegmentum (1986) |
Academic work | |
Institutions | University of New South Wales University of Sydney |
Glenda Margaret Halliday is an Australian neuroscientist. As of 2021,she is a professor at the University of Sydney and research fellow in the National Health and Medical Research Council (NHMRC). She was named 2022 NSW Scientist of the Year.
Halilday graduated with a BSc from the University of New South Wales (UNSW) in 1981. [1] She went on to graduate with a PhD from the Faculty of Medicine at the UNSW in 1986,with a thesis titled "The organization of the ventromedial mesencephalic tegmentum". [2] While undertaking her PhD she founded a donor program to enable study of Parkinson's disease in the brain.
Halliday is a research fellow of the NHMRC,first appointed to that role in 1990. [3] Working at UNSW,she was appointed professor of medicine in 2003 and subsequently professor of neuroscience in 2008. As of 2021 she is a professor and NHMRC leadership fellow based at the University of Sydney. [4]
Halliday's research focuses on neurodegeneration,including Parkinson's disease and frontotemporal dementia. [5] Her work has led to improved treatment of Parkinson's sufferers.
Halliday was elected a Fellow of the Australian Academy of Health and Medical Sciences in 2015 [6] and Fellow of the Australian Academy of Science in May 2021. [7] She was awarded the 2020 NHMRC Elizabeth Blackburn Investigator Grant Award for Leadership in Clinical Medicine and Science [8] and in 2021 won the international Robert A. Pritzker Prize for Leadership in Parkinson's Research. [9] She was named NSW Scientist of the Year at the 2022 NSW Premier's Prizes for Science and Engineering recognising her research on neurodegenerative diseases. [10]
Halliday was appointed as a Companion of the Order of Australia in the 2023 King's Birthday Honours for "eminent service to medical research in the field of neurodegenerative disorders,including the development of revised diagnostic criteria for Parkinson's disease,and as a mentor". [11]
Neuroscience Research Australia is an independent,not for profit medical research institute based in Sydney,Australia. The institute is made up of over 400 researchers specialising in research to improve the lives of people living with brain and nervous system disorders. The institute’s research spans neurodegeneration,including dementia and Parkinson’s disease;mental health and mental illness including bipolar disorder and schizophrenia;and translational neuroscience including falls prevention,pain and injury prevention.
Helen Christensen (AO) is the Scientia Professor of Mental Health at the University of New South Wales in Sydney. She has been the Board Director of the Black Dog Institute since 2022. She is also a former executive director and Chief Scientist at the Institute,having led the organisation from 2011 to 2021.
Katharina Gaus was a German-Australian immunologist and molecular microscopist. She was an NHMRC Senior Research Fellow and founding head of the Cellular Membrane Biology Lab,part of the Centre for Vascular Research at the University of New South Wales. Gaus used new super-resolution fluorescence microscopes to examine the plasma membrane within intact living cells,and study cell signalling at the level of single molecules to better understand how cells "make decisions". A key discovery of Gaus and her team was how T-cells decide to switch on the body's immune system to attack diseases. Her work is of importance to the development of drugs that can work with T-cells in support of the immune system.
Aleksandra Filipovska is an Australian scientist who is a professor,Deputy Director of the ARC Centre of Excellence in Synthetic Biology and NHMRC Investigator at the University of Western Australia,heading a research group at the Telethon Kids Institute. Specializing in biochemistry and molecular biology,she has made contributions to the understanding of human mitochondrial genetics in health and disease.
Michelle Haber is an Australian cancer researcher in the field of childhood cancer research.
George Paxinos AO DSc FASSA FAA FRSN FAHMS is a Greek Australian neuroscientist,born in Ithaca,Greece. He completed his BA in psychology at the University of California at Berkeley and his PhD at McGill University in Montreal,Canada. After a postdoctoral year at Yale University,he moved to the School of Psychology of the University of New South Wales in Sydney,Australia. He is currently an NHMRC Senior Principal Research Fellow at Neuroscience Research Australia and Scientia Professor of Medical Sciences at the University of New South Wales.
Bryce Vissel is an Australian neuroscientist who is a professor of neuroscience at the University of New South Wales. He is the Director of the Centre for Neuroscience and Regenerative Medicine (CNRM) at St Vincent's Hospital Sydney. He is a specialist in neurodegenerative diseases,such as Alzheimer's,Parkinson's,and the neural basis of learning,memory and movement.
Maree Rose Teesson,FAAHMS,FASSA,is an Australian expert on mental health. She is the Director of The Matilda Centre for Research in Mental Health and Substance Use and NHMRC Principal Research Fellow at the University of Sydney. She is also professorial fellow at the Black Dog Institute,UNSW.
Susan Margaret Pond is an Australian scientist and technologist,active in business and academia,and recognised for her contributions to medicine,biotechnology,renewable energy and sustainability. She is the current president of the Royal Society of New South Wales.
Naomi Ruth Wray is an Australian statistical geneticist at the University of Queensland,where she is a Professorial Research Fellow at the Institute for Molecular Bioscience and an Affiliate Professor in the Queensland Brain Institute. She is also a National Health and Medical Research Council (NHMRC) Principal Research Fellow and,along with Peter Visscher and Jian Yang,is one of the three executive team members of the NHMRC-funded Program in Complex Trait Genomics. She is also the Michael Days Chair of Psychiatric Genetics at Oxford University. Naomi pioneered the use of polygenic scores in human genetics,and has made significant contributions to both the development of methods and their clinical use.
Maria Kavallaris is an Australian scientist,based at the University of New South Wales' Children's Cancer Institute,where she is best known for her contributions to the field of cancer research. On 25 January 2019,Kavallaris was appointed a member of the Order of Australia.
Kaarin Anstey is an Australian Laureate Fellow and one of Australia's top dementia scientists. She is Co-Deputy Director of the ARC Centre of Excellence in Population Ageing Research (CEPAR) at the University of New South Wales,Australia,where she is Scientia Professor of Psychology. Kaarin Anstey is an Honorary Professor at the Australian National University and a Fellow of the Academy of the Social Sciences in Australia. She is a Director of the NHMRC Dementia Centre for Research Collaboration,Senior Principal Research Scientist at NeuRA and leads the NHMRC Centre of Research Excellence in Cognitive Health and the UNSW Ageing Futures Institute.
Lisa Maher is Professor and head of Viral Hepatitis Epidemiology,at the Kirby Institute for Infection and Immunity,at the University of New South Wales and was made Member of the Order of Australia in 2015. She was awarded an Elizabeth Blackburn Fellowship,in Public Health from the NHMRC,in 2014. She is a fellow of the Australian Academy of Health and Medical Sciences.
Louise Maple-Brown is an Australian endocrinologist. She is a clinical researcher at the Royal Darwin Hospital,serving as the hospital's Head of Endocrinology and as NHMRC Practitioner Fellow with the Menzies School of Health Research at Charles Darwin University. She leads a clinical research program within the Wellbeing and Preventable Chronic Diseases division of Menzies with a focus on diabetes in Indigenous Australians and provides clinical diabetes services to urban and remote Northern Territory communities.
Emily Banks is an Australian epidemiologist and public health physician,working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University,and a visiting professor at the University of Oxford.
Aletta E. "Alta" Schutte is a South African hypertension and heart disease expert based in Sydney,Australia. She is a SHARP Professor and Principal Theme Lead of Cardiac,Vascular and Metabolic Medicine at the University of New South Wales in Sydney,with a joint appointment as Professorial Fellow at the George Institute for Global Health. Until 2019 she was the Director of the Hypertension in Africa Research Team (HART),South African Research Chair (SARChI) and Director of the Medical Research Council Extramural Unit for Hypertension and Cardiovascular Disease at the North-West University in South Africa. She has fulfilled several leadership roles,including the President of the Southern African Hypertension Society,and President of the International Society of Hypertension,Secretary of the Australian Cardiovascular Alliance,and is the co-chair of the National Hypertension Taskforce of Australia.
Raina MacIntyre is an Australian epidemiologist and academic. She is the Professor of Global Biosecurity within the Kirby Institute at University of New South Wales and a National Health and Medical Research Council Principal Research Fellow,who leads a research program on the prevention and control of infectious diseases. She is an expert media advisor and commentator on Australia's response to COVID-19.
Carolyn Mary Sue is an Australian physician-scientist,professor and research director. She has been the Executive Director of the Kolling Institute of Medical Research since 2019 and is also Director of Neurogenetics at Royal North Shore Hospital,Director of the Centre of Excellence for Parkinson's Disease and Movement Disorders,and Director of the National Centre for Adult Stem Cell Research. Sue specialises in complex neurogenetic conditions and runs tertiary referral clinics for patients with diseases such as Parkinson's,mitochondrial diseases,and other inherited movement disorders. Her research has identified several previously-unknown mutations that cause neurogenetic disease.
Louisa Degenhardt is an Australian drug and alcohol researcher,and a scientia professor. She is also a senior principal research fellow with the National Health and Medical Research Council,part of the Centre for National Drug and Alcohol Research. She was elected as a fellow of the Australian Academy of Science in 2024. She received an Order of Australia in 2023.
Clara Chow AM FAHMS is an Australian cardiologist who is the program director of community-based cardiac services at Sydney's Westmead Hospital. She is a professor of medicine at the University of Sydney in the field of cardiovascular disease epidemiology,prevention,treatment and innovation. In 2019,she was appointed the academic director of the Westmead Applied Research Centre,a collaborative centre with a mission to better understand the causes of cardiovascular disease and translate their research to new treatments. She has also held the role of academic co-director of the Charles Perkins Centre since 2016.